{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:50:10Z","timestamp":1793137810158,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81973909"],"award-info":[{"award-number":["81973909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81874438"],"award-info":[{"award-number":["81874438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Neuromyelitis optica spectrum disorder (NMOSD) patients, especially those with anti-aquaporin-4 antibody positivity, a water channel expressed on astrocytes, is often accompanied by autoimmune diseases (ADs) including Sjogren syndrome (SS). Here, we report a case of a young Chinese woman with recurrent optic neuritis who was diagnosed with asymptomatic SS and NMOSD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 22-year-old Chinese woman suffered from optic neuritis for 3 years. The main manifestation was recurrent loss of vision. The anti-aquaporin-4 antibody was positive in the cerebrospinal fluid, and she was diagnosed with NMOSD. Other laboratory tests revealed positive anti-SSA and anti-SSB antibodies, and labial gland biopsy showed lymphocytic infiltration. She also fulfilled the international criteria for SS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>On the basis of recurrent vision loss and laboratory examination, we defined the patient with SS accompanied by NMOSD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>When the patient first experienced vision loss, the corticosteroid treatment in the external hospital was effective, and her visual acuity improved significantly. However, in several later attacks, such treatment was no longer obviously effective. Considering the patient's condition, she was treated with corticosteroids, cyclophosphamide, and immunoglobulin therapy on admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient's visual acuity was increased to the right eye 20\/800 and left eye finger counting when she was discharged from the hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>SS accompanied with NMOSD is common in clinical practice, and always with the positive Anti-AQP4 antibody as a potential biomarker. Patients with SS and NMOSD showed significant neurological symptoms and had a worse prognosis than SS patients with negative anti-AQP4 antibody because of cross-immunity between anti-SSA antibody and anti-AQP4 antibody. Rheumatologists and ophthalmologists should pay attention to this and perform appropriate tests.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023029","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T04:00:48Z","timestamp":1604548848000},"page":"e23029","source":"Crossref","is-referenced-by-count":7,"title":["Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder"],"prefix":"10.1097","volume":"99","author":[{"given":"Wei","family":"Zheng","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing"},{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dongfang Hospital Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8352.1","article-title":"Recent advances in primary Sjogren's syndrome","volume":"5","author":"Holdgate","year":"2016","journal-title":"F1000Res"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.msard.2018.12.028","article-title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","volume":"28","author":"Bibic","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00296-014-3066-3","article-title":"Neuromyelitis optica spectrum disorders associated with other autoimmune diseases","volume":"35","author":"Freitas","year":"2015","journal-title":"Rheumatol Int"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non\u2013organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"Iyer","year":"2014","journal-title":"Autoimmunity"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1016\/j.lpm.2012.06.002","article-title":"Central and peripheral neurological complications of primary Sj\u00f6gren's syndrome","volume":"41","author":"Fauchais","year":"2012","journal-title":"Presse M\u00e9d"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: a multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2014.11.020","article-title":"Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder","volume":"348","author":"Park","year":"2015","journal-title":"J Neurol Sci"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1352458508088941","article-title":"Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis","volume":"14","author":"Javed","year":"2008","journal-title":"Mult Scler"},{"key":"R12-20230916","first-page":"1067","article-title":"Primary Sjogren's syndrome with central nervous system involvement","volume":"30","author":"Alhomoud","year":"2009","journal-title":"Saudi Med J"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in Sj\u00f6gren's syndrome: a comprehensive review","volume":"18","author":"Martinnares","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd4226","article-title":"Aquaporins: important but elusive drug targets","volume":"13","author":"Verkman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(00)04140-4","article-title":"Defective cellular trafficking of lacrimal gland aquaporin-5 in Sj\u00f6gren's syndrome","volume":"357","author":"Tsubota","year":"2001","journal-title":"Lancet"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/0004-282X20140097","article-title":"Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu","volume":"72","author":"Carvalho","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","article-title":"A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset","volume":"72","author":"Nishiyama","year":"2009","journal-title":"Neurology"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult Scler"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12883-014-0162-7","article-title":"Neuromyelitis optica spectrum disorders without and with autoimmune diseases","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Neurol"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12883-014-0200-5","article-title":"Sj\u00f6gren's syndrome and neuromyelitis optica spectrum disorders (NMOSD): a case report and review of literature","volume":"14","author":"Jayarangaiah","year":"2014","journal-title":"BMC Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:50:58Z","timestamp":1694829058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023029"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":20,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023029","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]}}}